• 1.

    Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249:F324F337.

  • 2.

    Hostetter TH, et al.. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. J Am Soc Nephrol 2001; 12:13151325.

    • Search Google Scholar
    • Export Citation
  • 3.

    Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72:375380.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Kriz W, Lemley KV. A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 2015; 26:258269.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Williams SF, et al.. African Americans, hypertension and the renin angiotensin system. W J Cardiol 2014; 6:878889.

  • 6.

    Hsu CY, et al.. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003; 14:29022907.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    James PA, et al.. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311:507520.

    • Search Google Scholar
    • Export Citation
  • 8.

    Materson BJ, et al.. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328:914921.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Ely DL. Overview of dietary sodium effects on and interactions with cardiovascular and neuroendocrine functions. Am J Clin Nutr 1997; 65:594S605S.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    August P, et al.. Transforming growth factor beta and excess burden of renal disease. Trans Am Clin Climatol Assoc 2009; 120:6172.

  • 11.

    Wang A, et al.. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am J Physiol Renal Physiol 2007; 293:F1657F1665.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Antonipillai I, et al.. Transforming growth factor-beta is a renin secretagogue at picomolar concentrations. Am J Physiol 1993; 265:F537F541.

    • Search Google Scholar
    • Export Citation
  • 13.

    Kurihara H, et al.. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989; 159:14351440.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Harding K, et al.. Current state and future trends to optimize the care of chronic kidney disease in African Americans. Am J Nephrol 2017; 46:176186.

  • 15.

    Crews DC, et al.. Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants. Am J Kidney Dis 2012; 60:779786.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Hall YN, et al.. Characteristics of uninsured Americans with chronic kidney disease. J Gen Intern Med 2009; 24:917922.

  • 17.

    Salifu MO, et al.. Effect of ethnicity on the progression of diabetic kidney disease independent of glycemic control. Am J Nephrol 2009; 30:261267.

  • 18.

    Chen TK, et al.. APOL1 risk variants, incident proteinuria, and subsequent eGFR decline in blacks with hypertension-attributed CKD. Clin J Am Soc Nephrol 2017; 12:17711777.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Palmer ND, Freedman BI. APOL1 and progression of nondiabetic nephropathy. J Am Soc Nephrol 2013; 24:13441346.

  • 20.

    Herget-Rosenthal S, et al.. How does late nephrological co-management impact chronic kidney disease? An observational study. Int J Clin Pract 2010; 64:17841792.

    • Crossref
    • Search Google Scholar
    • Export Citation

Disparities in Risk Factors for Progression of CKD

  • 1 Moro Salifu, MD, is professor and chair of the department of medicine, SUNY Downstate Medical Center in Brooklyn, and Susanne B. Nicholas, MD, MPH, PhD, is associate professor of medicine in the divisions of nephrology and endocrinology, department of medicine, David Geffen School of Medicine at the University of California
Restricted access
Save